Profile | GDS5420 / 211505_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1196.18 | 82 |
GSM1296119 | B_lesional_pre-dose | 2733.49 | 93 |
GSM1296076 | C_lesional_pre-dose | 3000.51 | 93 |
GSM1296092 | D_lesional_pre-dose | 2776.9 | 92 |
GSM1296103 | E_lesional_pre-dose | 1373.85 | 84 |
GSM1296078 | F_lesional_pre-dose | 3256.3 | 93 |
GSM1296107 | G_lesional_pre-dose | 3135.68 | 94 |
GSM1296109 | H_lesional_pre-dose | 2051.03 | 90 |
GSM1296080 | I_lesional_pre-dose | 1183.89 | 81 |
GSM1296090 | J_lesional_pre-dose | 2894.18 | 93 |
GSM1296074 | K_lesional_pre-dose | 3164.2 | 93 |
GSM1296111 | L_lesional_pre-dose | 3537.03 | 95 |
GSM1296099 | M_lesional_pre-dose | 1998.56 | 89 |
GSM1296086 | O_lesional_pre-dose | 2640.08 | 92 |
GSM1296117 | P_lesional_pre-dose | 3363.16 | 95 |
GSM1296113 | Q_lesional_pre-dose | 3183 | 95 |
GSM1296096 | R_lesional_pre-dose | 1930.9 | 88 |
GSM1296105 | S_lesional_pre-dose | 1364.51 | 84 |
GSM1296098 | T_lesional_pre-dose | 1000.22 | 79 |
GSM1296101 | U_lesional_pre-dose | 1234.81 | 83 |
GSM1296121 | V_lesional_pre-dose | 2682.71 | 92 |
GSM1296088 | W_lesional_pre-dose | 2054.91 | 89 |
GSM1296082 | X_lesional_pre-dose | 3089.64 | 93 |
GSM1296115 | Y_lesional_pre-dose | 3389.5 | 95 |
GSM1296084 | Z_lesional_pre-dose | 1934.31 | 89 |
GSM1296072 | B_lesional_day8 | 2247.49 | 91 |
GSM1296069 | L_lesional_day8 | 2921.83 | 94 |
GSM1296071 | P_lesional_day8 | 2468.43 | 93 |
GSM1296070 | Y_lesional_day8 | 2762.6 | 94 |
GSM1296073 | V_lesional_day8 | 2988.56 | 93 |
GSM1296034 | A_lesional_day15 | 625.64 | 71 |
GSM1296041 | G_lesional_day15 | 3353.1 | 94 |
GSM1296035 | R_lesional_day15 | 1741.47 | 87 |
GSM1296038 | U_lesional_day15 | 1883.73 | 88 |
GSM1296047 | B_lesional_day15 | 2275.07 | 91 |
GSM1296039 | E_lesional_day15 | 2922.41 | 92 |
GSM1296042 | H_lesional_day15 | 2928.04 | 94 |
GSM1296043 | L_lesional_day15 | 2739.66 | 94 |
GSM1296037 | M_lesional_day15 | 1541.68 | 86 |
GSM1296046 | P_lesional_day15 | 2812.01 | 94 |
GSM1296044 | Q_lesional_day15 | 2502.76 | 93 |
GSM1296045 | Y_lesional_day15 | 2880.25 | 94 |
GSM1296025 | C_lesional_day15 | 1239.43 | 82 |
GSM1296033 | D_lesional_day15 | 1954.78 | 89 |
GSM1296027 | I_lesional_day15 | 1810.63 | 87 |
GSM1296032 | J_lesional_day15 | 2013.01 | 89 |
GSM1296024 | K_lesional_day15 | 1222.24 | 82 |
GSM1296031 | W_lesional_day15 | 1920.96 | 89 |
GSM1296028 | X_lesional_day15 | 2060.51 | 90 |
GSM1296029 | Z_lesional_day15 | 1641.32 | 87 |
GSM1296026 | F_lesional_day15 | 1799.39 | 87 |
GSM1296030 | O_lesional_day15 | 1902.64 | 88 |
GSM1296040 | S_lesional_day15 | 1118.56 | 81 |
GSM1296036 | T_lesional_day15 | 982.16 | 79 |
GSM1296048 | V_lesional_day15 | 2593.25 | 92 |
GSM1296059 | A_lesional_day43 | 1444.55 | 84 |
GSM1296066 | G_lesional_day43 | 3138.83 | 94 |
GSM1296060 | R_lesional_day43 | 1933.1 | 89 |
GSM1296063 | U_lesional_day43 | 2684.84 | 92 |
GSM1296064 | E_lesional_day43 | 2954.44 | 92 |
GSM1296067 | H_lesional_day43 | 1901.17 | 89 |
GSM1296062 | M_lesional_day43 | 1222.4 | 82 |
GSM1296068 | Q_lesional_day43 | 2600.99 | 93 |
GSM1296050 | C_lesional_day43 | 2157.47 | 90 |
GSM1296057 | D_lesional_day43 | 1710.05 | 87 |
GSM1296052 | I_lesional_day43 | 1900.45 | 88 |
GSM1296054 | J_lesional_day43 | 1281.39 | 83 |
GSM1296049 | K_lesional_day43 | 1416.35 | 84 |
GSM1296055 | W_lesional_day43 | 1979.44 | 89 |
GSM1296053 | X_lesional_day43 | 1260.02 | 83 |
GSM1296058 | Z_lesional_day43 | 1585.33 | 86 |
GSM1296051 | F_lesional_day43 | 2563.49 | 91 |
GSM1296056 | O_lesional_day43 | 2189.13 | 90 |
GSM1296065 | S_lesional_day43 | 2264.11 | 91 |
GSM1296061 | T_lesional_day43 | 847.79 | 76 |
GSM1296095 | A_non-lesional_pre-dose | 2267.63 | 90 |
GSM1296120 | B_non-lesional_pre-dose | 2352.64 | 91 |
GSM1296077 | C_non-lesional_pre-dose | 1300.49 | 83 |
GSM1296093 | D_non-lesional_pre-dose | 1349.96 | 84 |
GSM1296104 | E_non-lesional_pre-dose | 2553.46 | 91 |
GSM1296079 | F_non-lesional_pre-dose | 1693.16 | 87 |
GSM1296108 | G_non-lesional_pre-dose | 2433.71 | 92 |
GSM1296110 | H_non-lesional_pre-dose | 2135.99 | 91 |
GSM1296081 | I_non-lesional_pre-dose | 1126.03 | 81 |
GSM1296091 | J_non-lesional_pre-dose | 2481.1 | 92 |
GSM1296075 | K_non-lesional_pre-dose | 2820.45 | 93 |
GSM1296112 | L_non-lesional_pre-dose | 2612.33 | 94 |
GSM1296100 | M_non-lesional_pre-dose | 1513.62 | 86 |
GSM1296087 | O_non-lesional_pre-dose | 2196.07 | 90 |
GSM1296118 | P_non-lesional_pre-dose | 2358.72 | 92 |
GSM1296114 | Q_non-lesional_pre-dose | 3051.24 | 94 |
GSM1296097 | R_non-lesional_pre-dose | 1932.86 | 89 |
GSM1296106 | S_non-lesional_pre-dose | 1604.68 | 87 |
GSM1296102 | U_non-lesional_pre-dose | 1057.97 | 80 |
GSM1296122 | V_non-lesional_pre-dose | 2056.18 | 90 |
GSM1296089 | W_non-lesional_pre-dose | 2348.41 | 92 |
GSM1296083 | X_non-lesional_pre-dose | 1178.41 | 82 |
GSM1296116 | Y_non-lesional_pre-dose | 2563.07 | 93 |
GSM1296085 | Z_non-lesional_pre-dose | 1839.46 | 88 |